Detalhe da pesquisa
1.
Active enhancer and chromatin accessibility landscapes chart the regulatory network of primary multiple myeloma.
Blood;
131(19): 2138-2150, 2018 05 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29519805
2.
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.
Clin Cancer Res;
24(15): 3519-3527, 2018 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29716921